Cite

HARVARD Citation

    Rossfeld, K. et al. (2017). Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics. International journal of surgery. 2 (9), p. . [Online]. 
  
Back to record